Tempest Therapeutics, Inc. Comprehensive Income
Tempest Therapeutics, Inc. (TPST) reported Comprehensive Income of -$8.95 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-11-08
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$8.95M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$8.20M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-12-31 was -$6.32M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-09-30 was -$5.67M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$36.12M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$44.55M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$27.05M.
- Tempest Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$50.94M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 15 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 18 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 21 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 24 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 27 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 30 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 33 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | -$8.95M 10-Q · filed 2022-11-08 | -$26.61M 10-Q · filed 2022-11-08 | |||||||||||
| 2021-09-30 | -$8.20M 10-Q · filed 2022-11-08 | -$20.61M 10-Q · filed 2022-11-08 | |||||||||||
| 2020-12-31 | -$36.12M 10-K · filed 2021-03-29 | ||||||||||||
| 2019-12-31 | -$44.55M 10-K · filed 2021-03-29 | ||||||||||||
| 2018-12-31 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$12.00M derived: sum of 2 quarters · filed 2020-03-11 | -$19.68M derived: sum of 3 quarters · filed 2020-03-11 | -$27.05M 10-K · filed 2020-03-11 | |||||||||
| 2018-09-30 | -$5.67M 10-Q · filed 2018-11-09 | -$13.36M derived: sum of 2 quarters · filed 2018-11-09 | -$20.73M 10-Q · filed 2018-11-09 | -$29.26M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||
| 2018-06-30 | -$7.68M 10-Q · filed 2018-08-09 | -$15.05M 10-Q · filed 2018-08-09 | -$23.59M derived: sum of 3 quarters · filed 2018-08-09 | -$32.93M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||
| 2018-03-31 | -$7.37M 10-Q · filed 2018-05-03 | -$15.91M derived: sum of 2 quarters · filed 2018-05-03 | -$25.25M derived: sum of 3 quarters · filed 2018-11-09 | -$43.42M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||
| 2017-12-31 | -$8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$17.87M derived: sum of 2 quarters · filed 2018-11-09 | -$36.05M derived: sum of 3 quarters · filed 2018-11-09 | -$50.94M 10-K · filed 2018-03-15 | |||||||||
| 2017-09-30 | -$9.34M 10-Q · filed 2018-11-09 | -$27.52M derived: sum of 2 quarters · filed 2018-11-09 | -$42.41M 10-Q · filed 2018-11-09 | -$65.09M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||
| 2017-06-30 | -$18.18M 10-Q · filed 2018-08-09 | -$33.07M 10-Q · filed 2018-08-09 | -$55.75M derived: sum of 3 quarters · filed 2018-08-09 | -$75.07M derived: sum of 4 quarters · filed 2018-08-09 | |||||||||
| 2017-03-31 | -$14.89M 10-Q · filed 2018-05-03 | -$37.58M derived: sum of 2 quarters · filed 2018-05-03 | -$56.90M derived: sum of 3 quarters · filed 2018-05-03 | -$75.45M derived: sum of 4 quarters · filed 2018-05-03 | |||||||||
| 2016-12-31 | -$22.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$42.00M derived: sum of 2 quarters · filed 2018-03-15 | -$60.55M derived: sum of 3 quarters · filed 2018-03-15 | -$82.15M 10-K · filed 2018-03-15 | |||||||||
| 2016-09-30 | -$19.32M 10-Q · filed 2017-11-02 | -$37.87M derived: sum of 2 quarters · filed 2017-11-02 | -$59.47M 10-Q · filed 2017-11-02 | -$80.17M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||
| 2016-06-30 | -$18.55M 10-Q · filed 2017-08-03 | -$40.15M 10-Q · filed 2017-08-03 | -$60.85M derived: sum of 3 quarters · filed 2018-03-15 | -$78.75M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||
| 2016-03-31 | -$21.59M 10-Q · filed 2017-05-09 | -$42.29M derived: sum of 2 quarters · filed 2018-03-15 | -$60.19M derived: sum of 3 quarters · filed 2018-03-15 | -$77.78M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||
| 2015-12-31 | -$20.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$38.60M derived: sum of 2 quarters · filed 2018-03-15 | -$56.18M derived: sum of 3 quarters · filed 2018-03-15 | -$73.36M 10-K · filed 2018-03-15 | |||||||||
| 2015-09-30 | -$17.90M 10-Q · filed 2016-11-03 | -$35.48M derived: sum of 2 quarters · filed 2016-11-03 | -$52.66M 10-Q · filed 2016-11-03 | -$71.56M derived: sum of 4 quarters · filed 2017-03-02 | |||||||||
| 2015-06-30 | -$17.58M 10-Q · filed 2016-08-04 | -$34.76M 10-Q · filed 2016-08-04 | -$53.66M derived: sum of 3 quarters · filed 2017-03-02 | -$66.59M derived: sum of 4 quarters · filed 2017-03-02 | |||||||||
| 2015-03-31 | -$17.18M 10-Q · filed 2016-05-05 | -$36.07M derived: sum of 2 quarters · filed 2017-03-02 | -$49.01M derived: sum of 3 quarters · filed 2017-03-02 | -$58.90M derived: sum of 4 quarters · filed 2017-03-02 | |||||||||
| 2014-12-31 | -$18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$31.83M derived: sum of 2 quarters · filed 2017-03-02 | -$41.72M derived: sum of 3 quarters · filed 2017-03-02 | -$49.56M 10-K · filed 2017-03-02 | |||||||||
| 2014-09-30 | -$12.94M 10-Q · filed 2015-11-05 | -$22.83M derived: sum of 2 quarters · filed 2015-11-05 | -$30.66M 10-Q · filed 2015-11-05 | -$41.65M derived: sum of 4 quarters · filed 2016-02-26 | |||||||||
| 2014-06-30 | -$9.89M 10-Q · filed 2015-08-10 | -$9.90M 10-Q · filed 2014-08-07 | -$17.71M 10-Q · filed 2015-08-10 | -$28.71M derived: sum of 3 quarters · filed 2016-02-26 | -$35.57M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-03-31 | -$7.83M 10-Q · filed 2015-05-11 | -$18.82M derived: sum of 2 quarters · filed 2016-02-26 | -$25.68M derived: sum of 3 quarters · filed 2016-02-26 | -$31.70M derived: sum of 4 quarters · filed 2016-02-26 | -$52.99M 10-Q · filed 2014-05-08 | ||||||||
| 2013-12-31 | -$10.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$17.86M derived: sum of 2 quarters · filed 2016-02-26 | -$23.88M derived: sum of 3 quarters · filed 2016-02-26 | -$29.03M 10-K · filed 2016-02-26 | -$45.17M 10-K · filed 2014-02-27 | ||||||||
| 2013-09-30 | -$6.86M 10-Q · filed 2014-11-10 | -$12.88M derived: sum of 2 quarters · filed 2014-11-10 | -$18.04M 10-Q · filed 2014-11-10 | -$22.23M derived: sum of 4 quarters · filed 2015-03-16 | -$34.17M 10-Q · filed 2013-11-13 | ||||||||
| 2013-06-30 | -$6.02M 10-Q · filed 2014-08-07 | -$11.17M 10-Q · filed 2014-08-07 | -$15.37M derived: sum of 3 quarters · filed 2015-03-16 | -$18.49M derived: sum of 4 quarters · filed 2015-03-16 | -$27.31M 10-Q · filed 2013-08-13 | ||||||||
| 2013-03-31 | -$5.15M 10-Q · filed 2014-05-08 | -$9.35M derived: sum of 2 quarters · filed 2015-03-16 | -$12.47M derived: sum of 3 quarters · filed 2015-03-16 | -$15.70M derived: sum of 4 quarters · filed 2015-03-16 | -$21.29M 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$7.32M derived: sum of 2 quarters · filed 2015-03-16 | -$10.55M derived: sum of 3 quarters · filed 2015-03-16 | -$13.52M 10-K · filed 2015-03-16 | -$16.14M 10-K · filed 2013-02-25 | ||||||||
| 2012-09-30 | -$3.12M 10-Q · filed 2013-11-13 | -$6.35M derived: sum of 2 quarters · filed 2013-11-13 | -$9.32M 10-Q · filed 2013-11-13 | -$11.94M 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | -$3.23M 10-Q · filed 2013-08-13 | -$6.20M 10-Q · filed 2013-08-13 | -$8.82M 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | -$2.97M 10-Q · filed 2013-05-15 | ||||||||||||
| 2011-12-31 | -$2.62M 10-K · filed 2014-02-27 | ||||||||||||
| 2011-09-30 | -$774.00K 10-Q · filed 2012-11-13 | -$1.18M 10-Q · filed 2012-11-13 | |||||||||||
| 2011-06-30 | -$410.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |